Yamanaka on COVID-19
Antibody tests show pandemic is far from over
Few have acquired antibodies, with most still susceptible to infection
Few have acquired antibodies, with most still susceptible to infection
Cultural traits have helped but are no substitute for 'test, trace and isolate'
Patient's ordeal reveals imbalance between tests for recovery vs new cases
Kyoto University stem cell researcher battles misconceptions about COVID-19
Stay ahead with our exclusives on Asia;
the most dynamic market in the world.
Stay ahead with our exclusives on Asia
Get trusted insights from experts within Asia itself.
Get trusted insights from experts
within Asia itself.
Stay ahead with our exclusives on Asia; the most dynamic market in the world.
Get trusted insights from experts
within Asia itself.
Offer ends January 31st
You need a subscription to...
You need a subscription to:
Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.